Genetically Encoded Small Illuminants for 4D nucleome imaging

用于 4D 核组成像的基因编码小光源

基本信息

  • 批准号:
    9003351
  • 负责人:
  • 金额:
    $ 33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-30 至 2018-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): We propose to develop a novel technology that allows one to image the spatiotemporal dynamics of the epigenetic functional status of histones within the chromatin in real time, thus enabling 4D-nucleome imaging in living cells at single cell level. The proposed molecular imaging system is developed by using a one-bead-one-compound (OBOC) combinatorial library screen to identify short peptide(s) that activate fluorescence of organic dyes or molecular rotors. Activation of fluorescence is coupled to alterations of their chemical environment including conformational change upon ligand binding and phosphorylation, acetylation, methylation, or ubiquitination of the peptide. These peptides can then be genetically fused to target proteins such as histones to enable functional cellular imaging in living cells in real time. We will adapt our newly developed technology to the epigenetics studies in this application. Hypothesis: The Genetically Encoded Small Illuminant (GESI) technology, comprised of OBOC combinatorial peptide library design and serial screening of huge arrays of immobilized bead (~1 million diversities) under pre-defined conditions, enables identification of short peptide- dye pairs that can be used as genetically encoded illuminants to probe post-translational modification of histones in nucleosomes, temporary and spatially in living cells in real time, thus enabling 4D nucleome imaging. Fluorescently activated GESI sites can be covalently marked for subsequent correlative fluorescent and electron microscopy, and chromatin precipitation via dye/GESI interaction. Impact: GESI peptides can specifically bind to and activate the fluorescence of selected organic dyes. Some GESI peptides will do so only after binding to cellular components such as Ca2+, conformational changes or post-translational modifications (PTMs). Therefore, when expressed in a living cell, they can illuminate the spatiotemporal regulation and modification of proteins of interest. The genetic illuminants are small (1200-1900 daltons), thus can be readily inserted along the sequence of the native proteins without interfering with their physiological functions. Multiplexing is possible and allows us to study cross talks of different histone PMTs and/or recruitments of histone binding proteins in real time. Specific aims of the proposed project are: Aim 1. To design and synthesize a series of organic dyes suitable for GESI reporting in the nucleus of living cells. Aim 2. To develop GESIs to track the spatiotemporal dynamics of subtype of histone H2A (H2AX and H2AZ). Aim 3. To develop GESIs to newly identify acylations status of N-terminus histone H2A/H3 inside living cells.
 描述(申请人提供):我们建议开发一种新的技术,允许人们实时成像染色质中组蛋白的表观遗传功能状态的时空动态,从而能够在单个细胞的活细胞中进行4D-核基因组成像 水平。所提出的分子成像系统是通过使用一珠一化合物(OBOC)组合文库筛选来识别能够激活有机染料或分子转子的荧光的短肽(S)而开发的。荧光的激活与其化学环境的变化相耦合,包括配体结合时的构象变化和多肽的磷酸化、乙酰化、甲基化或泛素化。然后,这些多肽可以通过基因融合到目标蛋白质,如组蛋白,从而能够在活细胞中实时进行功能细胞成像。我们将把我们最新开发的技术应用于表观遗传学研究。假设:基因编码的小发光(GeSI)技术,包括OBOC组合肽库设计和预先定义的条件下对大量固定珠子(约100万个多样性)的连续筛选,能够识别短肽-染料对,这些短肽-染料对可以用作遗传编码光源,实时探测活细胞中核小体中临时和空间上的组蛋白翻译后修饰,从而实现4D核组成像。荧光激活的GeSI位点可以共价标记,用于随后的相关荧光和电子显微镜,以及通过染料/GeSI相互作用的染色质沉淀。影响:GeSI多肽可以与选定的有机染料特异结合并激活其荧光。一些GeSI多肽只有在与细胞成分如钙离子、构象变化或翻译后修饰(PTM)结合后才会这样做。因此,当它们在活细胞中表达时,可以阐明蛋白质的时空调节和修饰。 利息。遗传光源很小(1200-1900道尔顿),因此可以很容易地沿着天然蛋白质的序列插入,而不会干扰它们的生理功能。多路复用是可能的,并允许我们实时研究不同组蛋白PMT和/或组蛋白结合蛋白的招募的串扰。本项目的具体目标是:目的1.设计和合成一系列适合活细胞内GeSI报告的有机染料。目的2.建立GEIS示踪组蛋白H_2A亚型(H_2AX和H_2AZ)的时空动力学模型。目的3.建立组蛋白N-端组蛋白H_2A/H_3酰化状态的基因定位系统。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

R.Holland Cheng其他文献

R.Holland Cheng的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('R.Holland Cheng', 18)}}的其他基金

Cell-specific nanocarrier with endocytic and endosomolytic activities for therapeutic genome editing
具有内吞和内体溶解活性的细胞特异性纳米载体,用于治疗性基因组编辑
  • 批准号:
    10227681
  • 财政年份:
    2019
  • 资助金额:
    $ 33万
  • 项目类别:
Cell-specific nanocarrier with endocytic and endosomolytic activities for therapeutic genome editing
具有内吞和内体溶解活性的细胞特异性纳米载体,用于治疗性基因组编辑
  • 批准号:
    9810930
  • 财政年份:
    2019
  • 资助金额:
    $ 33万
  • 项目类别:
Cell-specific nanocarrier with endocytic and endosomolytic activities for therapeutic genome editing
具有内吞和内体溶解活性的细胞特异性纳米载体,用于治疗性基因组编辑
  • 批准号:
    10001068
  • 财政年份:
    2019
  • 资助金额:
    $ 33万
  • 项目类别:
Present Homologous and Heterologous Antigen with Hepatitis E Virus
戊型肝炎病毒存在同源和异源抗原
  • 批准号:
    8507842
  • 财政年份:
    2012
  • 资助金额:
    $ 33万
  • 项目类别:
IN-SITU STUDY OF BUDDING AND ASSEMBLY OF SEMLIKI FOREST VIRUS PARTICLES
SEMLIKI 森林病毒颗粒出芽和组装的原位研究
  • 批准号:
    7598345
  • 财政年份:
    2007
  • 资助金额:
    $ 33万
  • 项目类别:
TOMOGRAPHY OF VIRUS PARTICLE ASSEMBLY IN SITU
病毒颗粒组装原位断层扫描
  • 批准号:
    6976405
  • 财政年份:
    2004
  • 资助金额:
    $ 33万
  • 项目类别:
IVEM TOMOGRAPHY OF HIGH PRESSURE FROZEN & FREEZE SUBSTITUTED VIRUS STRUCTURES
高压冷冻 IVEM 断层扫描
  • 批准号:
    6653372
  • 财政年份:
    2002
  • 资助金额:
    $ 33万
  • 项目类别:
IVEM TOMOGRAPHY OF HIGH PRESSURE FROZEN & FREEZE SUBSTITUTED VIRUS STRUCTURES
高压冷冻 IVEM 断层扫描
  • 批准号:
    6491855
  • 财政年份:
    2001
  • 资助金额:
    $ 33万
  • 项目类别:
IVEM TOMOGRAPHY OF HIGH PRESSURE FROZEN & FREEZE SUBSTITUTED VIRUS STRUCTURES
高压冷冻 IVEM 断层扫描
  • 批准号:
    6423438
  • 财政年份:
    2000
  • 资助金额:
    $ 33万
  • 项目类别:
IVEM TOMOGRAPHY OF HIGH PRESSURE FROZEN & FREEZE SUBSTITUTED VIRUS STRUCTURES
高压冷冻 IVEM 断层扫描
  • 批准号:
    6119676
  • 财政年份:
    1999
  • 资助金额:
    $ 33万
  • 项目类别:

相似海外基金

Greasing endocytosis in plants - understanding the role of S-acylation in receptor kinase function and internalisation
植物中的润滑内吞作用 - 了解 S-酰化在受体激酶功能和内化中的作用
  • 批准号:
    BB/Y003756/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33万
  • 项目类别:
    Research Grant
Ghrelin de-acylation inhibitors as novel compounds for Parkinson's dementia
生长素释放肽去酰化抑制剂作为治疗帕金森痴呆症的新型化合物
  • 批准号:
    MR/Y503435/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33万
  • 项目类别:
    Research Grant
S-acylation-dependent regulation of cytokine receptor signaling and cardiac maladaptation
细胞因子受体信号传导和心脏适应不良的 S-酰化依赖性调节
  • 批准号:
    10561406
  • 财政年份:
    2023
  • 资助金额:
    $ 33万
  • 项目类别:
Comprehensive analysis of acidic patch binder using histone acylation catalysts
使用组蛋白酰化催化剂综合分析酸性贴片粘合剂
  • 批准号:
    22KJ1113
  • 财政年份:
    2023
  • 资助金额:
    $ 33万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
S-Acylation of transmembrane proteins in the early secretory pathway
早期分泌途径中跨膜蛋白的 S-酰化
  • 批准号:
    BB/X001504/1
  • 财政年份:
    2023
  • 资助金额:
    $ 33万
  • 项目类别:
    Research Grant
N-terminal acylation and sorting of Helicobacter pylori lipoproteins and their role in host response to infection
幽门螺杆菌脂蛋白的 N 末端酰化和分选及其在宿主感染反应中的作用
  • 批准号:
    10584620
  • 财政年份:
    2022
  • 资助金额:
    $ 33万
  • 项目类别:
The Molecular Mechanisms of Glycolytic Enzyme S-acylation in Neurons
神经元糖酵解酶S-酰化的分子机制
  • 批准号:
    576016-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 33万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Anti-CRISPR-mediated Acylation and Bioreversible Esterification for Precision Genome Editing
用于精准基因组编辑的抗 CRISPR 介导的酰化和生物可逆酯化
  • 批准号:
    10657417
  • 财政年份:
    2022
  • 资助金额:
    $ 33万
  • 项目类别:
High Throughput Screen for Inhibitors of the YEATS2 Histone Acylation Reader
YEATS2 组蛋白酰化酶抑制剂的高通量筛选
  • 批准号:
    10389517
  • 财政年份:
    2022
  • 资助金额:
    $ 33万
  • 项目类别:
Roles of KAT8 complexes in governing histone acylation and mouse cerebral development
KAT8复合物在控制组蛋白酰化和小鼠大脑发育中的作用
  • 批准号:
    RGPIN-2019-07122
  • 财政年份:
    2022
  • 资助金额:
    $ 33万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了